Klaria strengthens its drug delivery platform with acquisition of innovative technology with potential to revolutionize delivery of large molecules
(WorldNews Sweden)

With this acquisition, Klaria adds a second pillar to its platform with a proprietary technology that can be used both on a stand-alone basis and in combination with its Alginate Film. It is the potential to combine the technologies of the two companies that is of the highest interest to Klaria. With the combination of the two technologies, large molecules would be delivered in Klaria`s Alginate Film. For example, the administration of vaccines that today require an injection would be vastly simplified into the application of Klaria`s stamp-sized film, placed under the tongue or lip of the subject. Jesper Wiklund, Managing Director and co-founder of WBC Technologies stated: `Our technology...